Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
NPJ Parkinson'S Disease
|
July 12, 2025
Regional-specific structural and functional changes of posterior cerebellar vermis across different stages of Parkinson's disease with gait dysfunction
Liuzhenxiong Yu, Jinying Han, Xin Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 27, 2023
A General and Convenient Peptide Self-Assembling Mechanism for Developing Supramolecular Versatile Nanomaterials Based on The Biosynthetic Hybrid Amyloid-Resilin Protein
Junjun Wu, Lin Zhou, Hu Peng, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood
Junjun Wu, Neal Green, Rajeev Hotchandani, et al.
Journal of Medicinal Chemistry
|
September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma
Wei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)
Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Trials
|
March 28, 2026
The efficacy and safety of precision repetitive transcranial magnetic stimulation in alleviating motor symptoms in Parkinson's disease (PRESS-PD): a randomized, double-blind, multicenter, placebo-controlled trial
Xin Chen, Gong-Jun Ji, Rong Ye, et al.
Journal of Medicinal Chemistry
|
August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles
Neal Green, Yonghan Hu, Kristin Janz, et al.
Journal of Medicinal Chemistry
|
August 21, 2007
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site
Douglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets
Derek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Journal of Medicinal Chemistry
|
October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitors
Derek C Cole, Eric S Manas, Joseph R Stock, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
NPJ Parkinson'S Disease
|
July 12, 2025
Regional-specific structural and functional changes of posterior cerebellar vermis across different stages of Parkinson's disease with gait dysfunction
Liuzhenxiong Yu, Jinying Han, Xin Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 27, 2023
A General and Convenient Peptide Self-Assembling Mechanism for Developing Supramolecular Versatile Nanomaterials Based on The Biosynthetic Hybrid Amyloid-Resilin Protein
Junjun Wu, Lin Zhou, Hu Peng, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood
Junjun Wu, Neal Green, Rajeev Hotchandani, et al.
Journal of Medicinal Chemistry
|
September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma
Wei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)
Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Trials
|
March 28, 2026
The efficacy and safety of precision repetitive transcranial magnetic stimulation in alleviating motor symptoms in Parkinson's disease (PRESS-PD): a randomized, double-blind, multicenter, placebo-controlled trial
Xin Chen, Gong-Jun Ji, Rong Ye, et al.
Journal of Medicinal Chemistry
|
August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles
Neal Green, Yonghan Hu, Kristin Janz, et al.
Journal of Medicinal Chemistry
|
August 21, 2007
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site
Douglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets
Derek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Journal of Medicinal Chemistry
|
October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitors
Derek C Cole, Eric S Manas, Joseph R Stock, et al.
Page
of 14